After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CLOV belongs to the Healthcare sector of the NASDAQ while operating in the Healthcare Plans industry. The current market capitalization of Clover Health Investments Corp is $1.54B. A total of 5.01 million shares were traded on the day, compared to an average of 8.98M shares.
In the most recent transaction, Reynoso Jamie L. sold 4,914 shares of CLOV for 3.09 per share on Sep 17 ’25. After the transaction, the CEO, Medicare Advantage now owns 3,053,890 company shares. In a previous transaction on Sep 17 ’25, JAMIE REYNOSO bought 4,914 shares at 3.12 per share.
Among the insiders who bought shares, Loengard Anna U acquired of 26,500 shares on Aug 13 ’25 at a per-share price of $2.59. This resulted in the Director holding 29,610 shares of CLOV after the transaction. In another insider transaction, Garipalli Vivek bought 415,000 shares at $2.24 per share on Aug 07 ’25. Company shares held by the Director now total 1,824,267.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CLOV has a high of $4.87 and a low of $2.12.
As of this writing, CLOV has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.02 per share and a lower estimate of $0.02. The company reported an EPS of -$0.02 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CLOV’s latest balance sheet shows that the firm has $615.25M in Cash & Short Term Investments as of fiscal 2021. There were $27.83M in debt and $372.62M in liabilities at the time. Its Book Value Per Share was $0.71, while its Total Shareholder’s Equity was $539.32M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLOV is Buy with a score of 3.80.
